Literature DB >> 24391070

[Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations].

Dagmara Borkowska1, Elżbieta Radzikowska, Jolanta Załęska, Jerzy Ziołkowski, Magdalena Klatt, Zofia Zwolska, Ewa Augustynowicz-Kopeć, Kazimierz Roszkowski-Śliż.   

Abstract

Until recently, the basic test to identify latent tuberculosis infection (LTBI) was the tuberculin skin test, despite its limitations in the form of low sensitivity and specificity. Currently, Interferon Gamma Release Assays from peripheral blood are used for a rapid diagnosis of LTBI and measurement of the interferon gamma (IFN-g) levels secreted by specific T cells stimulated with Mycobacterium tuberculosis antigens. Detection of LTBI is important in the control of people potentially at risk of TB disease, such as people remaining in close contact with BK (+) tb patient and for patients evaluated for biological treatment. The paper presents the value of IGRA in three selected clinical situations: in two cases of latent tuberculosis infection and in one case of active tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24391070     DOI: 10.5603/PiAP.2014.0007

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  1 in total

1.  A comparative analysis of tuberculosis in vitro screening in pemphigus patients selected for treatment with rituximab.

Authors:  Magdalena Jałowska; Justyna Gornowicz-Porowska; Agnieszka Seraszek-Jaros; Elżbieta Kaczmarek; Monika Bowszyc-Dmochowska; Paweł Bartkiewicz; Marian Dmochowski
Journal:  Postepy Dermatol Alergol       Date:  2021-09-14       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.